Results 91 to 100 of about 84,856 (259)

Atezolizumab-induced Sclerosing Cholangitis in a patient with lung cancer: A case report

Cancer Treatment and Research Communications, 2021
Atezolizumab is an immune checkpoint inhibitor that is a key drug in non-small-cell lung cancer treatment. However, it can cause immune-related adverse events, including liver injury.
Shinji Nabeshima, Masahiro Yamasaki, Naoko Matsumoto, Shintaro Takaki, Yumi Nishi, Kazuma Kawamoto, Masaya Taniwaki, Nobuyuki Ohashi, Noboru Hattori   +8 more
doaj  

Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies

Annals of Hepatology, 2020
Primary biliary cholangitis and primary sclerosing cholangitis are rare diseases affecting the bile ducts and the liver. The limited knowledge of their pathogenesis leads to limited therapeutic options.
Alessio Gerussi, Daphne D’Amato, Laura Cristoferi, Sarah Elizabeth O’Donnell, Marco Carbone, Pietro Invernizzi   +5 more
doaj  

IgG4-associated sclerosing cholangitis: a diagnosis that may change the course of events (review of the literature and a clinical case)

Alʹmanah Kliničeskoj Mediciny, 2018
Immunoglobulin G4-associated sclerosing cholangitis (IgG4-SC) can mimic primary sclerosing cholangitis, cholangiocarcinoma, and pancreatic adenocarcinoma. Its proper diagnosis allows for an adequate therapy and an improvement of the outcomes. The article
E. V. Vinnitskaya, T. Yu. Khaimenova, E. S. Sbikina, R. I. Alexandrova, Yu. G. Sandler   +4 more
doaj   +1 more source

Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.

Gastroenterology, 2017
BACKGROUND & AIMS Primary sclerosing cholangitis (PSC) is an orphan hepatobiliary disorder associated with inflammatory bowel disease (IBD). We aimed to estimate the risk of disease progression based on distinct clinical phenotypes in a large ...
T. Weismüller, P. Trivedi, A. Bergquist, M. Imam, H. Lenzen, C. Ponsioen, K. Holm, D. Gotthardt, M. Färkkilä, H. Marschall, D. Thorburn, R. Weersma, J. Fevery, T. Mueller, O. Chazouilleres, K. Schulze, K. Lazaridis, S. Almér, S. Pereira, C. Levy, A. Mason, S. Naess, C. Bowlus, A. Floreani, E. Halilbasic, Kidist K. Yimam, P. Milkiewicz, U. Beuers, D. Huynh, A. Parés, C. Manser, G. Dalekos, B. Eksteen, P. Invernizzi, C. Berg, G. Kirchner, C. Sarrazin, V. Zimmer, L. Fabris, F. Braun, M. Marzioni, B. Juran, K. Said, C. Rupp, K. Jokelainen, Maria Benito de Valle, F. Saffioti, A. Cheung, M. Trauner, C. Schramm, R. Chapman, T. Karlsen, E. Schrumpf, C. Strassburg, M. Manns, K. Lindor, G. Hirschfield, B. Hansen, K. Boberg   +58 more
semanticscholar   +1 more source

Primary Sclerosing Cholangitis [PDF]

New England Journal of Medicine, 2016
Roberto Valente, Marco Del Chiaro, Urban Arnelo   +2 more
openaire   +7 more sources

Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis.

Journal of Hepatology, 2021
M. Reich, L. Spomer, C. Klindt, Katharina Fuchs, J. Stindt, K. Deutschmann, J. Höhne, E. Liaskou, J. Hov, T. Karlsen, U. Beuers, J. Verheij, Sofía Ferreira-González, G. Hirschfield, S. Forbes, C. Schramm, I. Esposito, D. Nierhoff, P. Fickert, C. Fuchs, M. Trauner, María García-Beccaria, G. Gabernet, S. Nahnsen, Jan-Philipp Mallm, M. Vogel, K. Schoonjans, Tobias Lautwein, K. Köhrer, D. Häussinger, T. Luedde, M. Heikenwalder, V. Keitel   +32 more
semanticscholar   +1 more source

Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis

World Journal of Gastroenterology, 2017
AIM To characterize the gut bacterial microbiota of patients with primary sclerosing cholangitis (PSC) and ulcerative colitis (UC). METHODS Stool samples were collected and relevant clinical data obtained from 106 study participants, 43 PSC patients with
L. Bajer, M. Kverka, M. Kostovčík, P. Mačinga, J. Dvorak, Zuzana Stehlikova, J. Březina, P. Wohl, J. Spicak, P. Drastich   +9 more
semanticscholar   +1 more source

Association of primary sclerosing cholangitis and celiac disease: Fact or fancy? [PDF]

, 1989
Erik Schrumpf
openalex   +1 more source

58. DIFFERING EXPRESSION OF ANTIBODIES TO DOUBLE STRANDED DNA IN AUTOIMMUNE CHRONIC ACTIVE HEPATITIS (aCAH) & PRIMARY SCLEROSING CHOLANGITIS (PSC) [PDF]

, 1987
Mark Peakman, L. R. Davis, Giorgina Mieli‐Vergani, A P Mowat, Diego Vergani   +4 more
openalex   +1 more source

Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo-controlled trial [PDF]

, 1992
Ulrich Beuers, Ulrich Spengler, Wolfgang Kruis, Ü. Aydemir, B. Wiebecke, Walter Heldwein, M. Weinzierl, Gerd R. Pape, Tilman Sauerbruch, G. Paumgartner   +9 more
openalex   +1 more source